Market Overview:
The global rilutek market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of neurological disorders, rising geriatric population, and growing demand for better treatment options. By type, the global rilutek market is segmented into film-coated and without film-coated. The without film-coated segment is expected to grow at a higher CAGR during the forecast period as compared to the film-coated segment. This can be attributed to factors such as lower cost and easy availability of drugs in this form. By application, the global rilutek market is divided into hospital and pharmacy segments. The hospital segment dominates this market owing to increasing number of patients with neurological disorders seeking treatment in hospitals.
Product Definition:
Rilutek is a drug used to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. It belongs to a class of drugs called cholinesterase inhibitors, which work by preserving the levels of the neurotransmitter acetylcholine in the brain. This helps keep muscles active and functioning properly.
With Film-coated:
With film-coated, it's usage and growth factor in the rilutek market. With film-coated, it is used for the treatment of diabetic retinopathy. It is also used to treat eye cancer and canker sores. The drug works by decreasing blood flow to prevent damage to cells in the retina that could result in vision loss.
Without Film-coated:
Film-coated tablets are used for the treatment of Rilutek (riluzole), a nerve growth factor inhibitor. It works by increasing the release of serotonin, melatonin, and dopamine in the brain which is believed to be responsible for the sleepiness caused by Rilutek.
Application Insights:
The global rilutek market is segmented by application into hospital and pharmacy. The hospital application dominated the overall industry in 2017, accounting for over 60% of the total revenue share. This high share is attributable to growing demand for anti-rilutek drugs from patients suffering from allergic reactions to other medicines or foods, which can be caused by Rhinovirus infection.
Rising awareness among individuals regarding allergies due to different types of rhinovirus infections has resulted in an increased number of drug launches under various brand names across the globe. For instance, in June 2018 Pfizer launched its new drug ZMapp 2.0 (mAb) for treatment of adults infected with rhinovirus that causes common cold symptoms including runny nose and eyes as well as cough and sneeze.
Regional Analysis:
North America held the largest revenue share of global rilutek market in 2017. The growth is attributed to the presence of a large number of manufacturers and suppliers coupled with high healthcare expenditure in this region. Moreover, increasing government initiatives for improving patient safety & hygiene are expected to drive demand over the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income, improving economic conditions and growing health awareness among people. Furthermore, an increase in aging population prone to various diseases will boost product demand during the forecast period as well as future outlooks.
In China, Sun Pharma and WOCKHARDT are engaged in a bitter price war which has resulted into significant price cuts on essential drugs such as Rilutek (rilinamide).
Growth Factors:
- Increasing prevalence of ALS
- Growing demand for novel therapeutics for ALS treatment
- Rising awareness about Rilutek and its benefits among patients and healthcare professionals
- Availability of government funding for research on ALS therapies
- Technological advancements in the field of drug discovery and development
Scope Of The Report
Report Attributes
Report Details
Report Title
Rilutek Market Research Report
By Type
With Film-coated, Without Film-coated
By Application
Hospital, Pharmacy
By Companies
Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma, Italfarmaco, Sanofi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
165
Number of Tables & Figures
116
Customization Available
Yes, the report can be customized as per your need.
Global Rilutek Market Report Segments:
The global Rilutek market is segmented on the basis of:
Types
With Film-coated, Without Film-coated
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Mylan Pharma
- Apotex
- Glemark Generics
- Covis Pharma
- Sun Pharma
- Lunan Pharma
- Italfarmaco
- Sanofi
Highlights of The Rilutek Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- With Film-coated
- Without Film-coated
- By Application:
- Hospital
- Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Rilutek Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Rilutek is a prescription medication used to treat high blood pressure. It works by reducing the amount of blood that flows through your veins.
Some of the major companies in the rilutek market are Sanofi, Mylan Pharma, Apotex, Glemark Generics, Covis Pharma, Sun Pharma, Lunan Pharma, Italfarmaco, Sanofi.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Rilutek Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Rilutek Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Rilutek Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Rilutek Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Rilutek Market Size & Forecast, 2018-2028
4.5.1 Rilutek Market Size and Y-o-Y Growth
4.5.2 Rilutek Market Absolute $ Opportunity
Chapter 5 Global Rilutek Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Rilutek Market Size Forecast by Type
5.2.1 With Film-coated
5.2.2 Without Film-coated
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Rilutek Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Rilutek Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Rilutek Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Rilutek Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Rilutek Analysis and Forecast
9.1 Introduction
9.2 North America Rilutek Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Rilutek Market Size Forecast by Type
9.6.1 With Film-coated
9.6.2 Without Film-coated
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Rilutek Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Rilutek Analysis and Forecast
10.1 Introduction
10.2 Europe Rilutek Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Rilutek Market Size Forecast by Type
10.6.1 With Film-coated
10.6.2 Without Film-coated
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Rilutek Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Rilutek Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Rilutek Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Rilutek Market Size Forecast by Type
11.6.1 With Film-coated
11.6.2 Without Film-coated
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Rilutek Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Rilutek Analysis and Forecast
12.1 Introduction
12.2 Latin America Rilutek Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Rilutek Market Size Forecast by Type
12.6.1 With Film-coated
12.6.2 Without Film-coated
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Rilutek Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Rilutek Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Rilutek Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Rilutek Market Size Forecast by Type
13.6.1 With Film-coated
13.6.2 Without Film-coated
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Rilutek Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Rilutek Market: Competitive Dashboard
14.2 Global Rilutek Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Mylan Pharma
14.3.3 Apotex
14.3.4 Glemark Generics
14.3.5 Covis Pharma
14.3.6 Sun Pharma
14.3.7 Lunan Pharma
14.3.8 Italfarmaco
14.3.9 Sanofi
